Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Position Increased by Rhumbline Advisers
Rhumbline Advisers raised its holdings in shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO – Free Report) by 105.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,600 shares of the company’s stock after purchasing an additional 4,424 shares during the period. […]
Rhumbline Advisers raised its holdings in shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO – Free Report) by 105.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,600 shares of the company’s stock after purchasing an additional 4,424 shares during the period. […]
